Preparation method of targeted temperature-sensitive drug-loaded composite microspheres based on attapulgite
By preparing targeted thermosensitive drug-loaded composite microspheres based on attapulgite, and combining attapulgite, gypenosides, inulin and folic acid with lauric acid coating, a multifunctional synergistic drug delivery system was constructed. This system solved the problems of poor targeting and inaccurate release of chemotherapy drugs, and achieved efficient and low-toxicity tumor treatment.
Patent Information
- Application Number
- CN202610138909.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-31
- Publication Date
- 2026-05-29
AI Technical Summary
Existing chemotherapy drugs suffer from poor targeting, wide systemic distribution, and significant toxic side effects, making it difficult to achieve precise control of drug release and selectivity for tumor tissues. Furthermore, existing systems have limited functionality, making it difficult to achieve precise controlled release through colon-specific delivery, active tumor targeting, and near-infrared light triggering.
A method for preparing targeted thermosensitive drug-loaded composite microspheres based on attapulgite was adopted. By purifying a mixture of attapulgite, gypenosides, inulin and folic acid, and combining spray drying technology and melt impregnation method, lauric acid was coated on the surface of the primary drug-loaded composite microspheres to construct a multifunctional synergistic drug delivery system with colon-targeting, active targeting and near-infrared photothermal triggering.
It achieves intelligent controlled release of drugs, improves treatment efficacy, reduces systemic toxic side effects of chemotherapy, and realizes highly efficient and low-toxicity synergistic treatment. It also has precise controlled release functions such as colon-targeted, active-targeted, and near-infrared photothermal triggering.